Standout Papers
Immediate Impact
3 from Science/Nature 55 standout
Citing Papers
Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline–trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial
2023 Standout
Treatment of Tobacco Smoking
2022 Standout
Works of J. Wesley Boyd being referenced
Smoking and Mental Illness
2000 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| J. Wesley Boyd | 300 | 469 | 1277 | 367 | 3 | 2.0k | ||
| et al | 109 | 696 | 819 | 198 | 14 | 2.0k | ||
| Fay Stetner | 147 | 241 | 987 | 131 | 10 | 1.4k | ||
| Ellen S. Burgess | 287 | 480 | 710 | 135 | 21 | 1.9k | ||
| Fiore Mc | 245 | 195 | 2492 | 683 | 8 | 3.1k | ||
| Scott Fairhurst | 410 | 495 | 1785 | 788 | 5 | 3.1k | ||
| Kevin Smith | 213 | 121 | 1111 | 383 | 9 | 2.9k | ||
| Meghan Hamel | 100 | 248 | 1223 | 421 | 10 | 2.4k | ||
| Mark H. Balabanis | 299 | 424 | 1486 | 298 | 18 | 2.7k | ||
| Susan L. Kenford | 201 | 360 | 1689 | 229 | 16 | 2.2k | ||
| Gary L. Humfleet | 403 | 420 | 1772 | 346 | 45 | 2.5k |
All Works
Login with ORCID to disown or claim papers
Loading papers...